Fan et al. utilized cancer cell membrane-coated mesoporous silica nanoparticles (CM-MSN) loaded with curcumin (CM-MSN@CUR) to upregulate HO-1 and inhibit GPX4 in GC cell lines (SGC-7901, MGC-803) and xenograft tumor models. Here, GPX4 is linked to cancer.